Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 14:13:1082154.
doi: 10.3389/fimmu.2022.1082154. eCollection 2022.

Oxygen level is a critical regulator of human B cell differentiation and IgG class switch recombination

Affiliations

Oxygen level is a critical regulator of human B cell differentiation and IgG class switch recombination

Jana Koers et al. Front Immunol. .

Abstract

The generation of high-affinity antibodies requires an efficient germinal center (GC) response. As differentiating B cells cycle between GC dark and light zones they encounter different oxygen pressures (pO2). However, it is essentially unknown if and how variations in pO2 affect B cell differentiation, in particular for humans. Using optimized in vitro cultures together with in-depth assessment of B cell phenotype and signaling pathways, we show that oxygen is a critical regulator of human naive B cell differentiation and class switch recombination. Normoxia promotes differentiation into functional antibody secreting cells, while a population of CD27++ B cells was uniquely generated under hypoxia. Moreover, time-dependent transitions between hypoxic and normoxic pO2 during culture - reminiscent of in vivo GC cyclic re-entry - steer different human B cell differentiation trajectories and IgG class switch recombination. Taken together, we identified multiple mechanisms trough which oxygen pressure governs human B cell differentiation.

Keywords: B cells; antibody-secreting cell; class switch recombination; differentiation; germinal center; hypoxia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Differential pO2 controls human B cell differentiation into CD27+ and antibody secreting cell compartments. (A) Schematic overview of B cell in vitro culture system. 250 resting human naive B cells (CD19+CD27-IgD+) were stimulated using a human CD40L-expressing feeder cell layer (subtype ‘High’ (12),); recombinant human IL-4 (25ng/ml) and IL-21 (50ng/ml); and cultured at 5% pCO2 and 21, 3, or 1% pO2 for a maximum of 11 days. (B) Representative biaxial CD27/CD38 FACS plots after 5, 7, and 11 days of culture at 21, 3, or 1% pO2. (C) Quantification of the percentages of CD27 and CD38 subpopulations within total CD19+ B cells over time (n = 9). (D) CD138 expression within the CD27+CD38+ antibody secreting cell population (n = 6). (E) Cumulative secretion of IgM and IgG measured in culture supernatants after 11 days (n = 9). (F) gMFI of AID expression over time (n = 3). (G) Percentage of IgG+ cells within CD19+ B cells, combined surface and intracellular staining (n = 8). Bars represent means of biological replicates each composed of 2 technical replicates in (D, F) 2, (E, G) 3 or (C) 4 independent experiments. Statistical differences were determined using (C, F) mixed-effects analysis using Tukey’s test for multiple comparisons (D, E, G) repeated measures one-way ANOVA using Tukey’s test for multiple comparisons. *p < 0.05, ***p < 0.001, ****p < 0.0001.
Figure 2
Figure 2
Proliferative human B cells adopt glycolysis and mitochondrial-associated ROS levels are increased in hypoxic cultures (A) gMFI of HIF1α expression over time (n = 6) and histogram overlay at day 3. (B) Glucose uptake (2-NBG; (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose) by B cells cultured for 7 days (n = 9). Lactate production measured in supernatants at day 11 in µM per 104 cultured B cells (n = 6). (C) gMFI of MitoTracker GREEN, MitoTracker RED, and MitoSOX after 7 days of culture (n = 8) indicative for mitochondrial mass, potential and ROS production, respectively. (D) Fatty acid (FA) uptake by B cells cultured for 7 days (n = 5). Bars represent means of biological replicates each composed of two technical replicates of (E) 1, (A, C) 2 or (B, D) 3 independent experiments. Statistical differences were determined using a repeated measures one-way ANOVA using Tukey’s test for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 3
Figure 3
pO2 steers canonical signaling pathways that direct naive B cell differentiation pathways (A-D) gMFI of (A) BCL-6 (n = 6) (B) IRF4 (n = 6) (C) PNA+ (n = 6) (D) CD95 (n = 6) (E) CD86 (n = 6) (F) NFκB active subunit p65 (n = 9) (G) c-Myc (n = 9) (H-I) gMFI of (H) tSTAT6 and pSTAT6 and (I) tSTAT3 and pSTAT3 over time in culture (n = 6) and (left panels) representative histogram overlays of pSTAT and tSTAT expression on day 5 of culture (J) gMFI of PAX5, BLIMP1 and %XBP-1s+ in BLIMP1hi cells (n=6) on day 7 (A-J) Bars represent means of biological replicates each composed of two technical replicates of 2 (H-J) or (A-G) 3 independent experiments (A-I) Differences in gMFI were determined using mixed-effects analysis using Tukey’s test for multiple comparisons. (J) Differences in gMFI were determined using repeated measures one-way ANOVA using Tukey’s tests for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 4
Figure 4
Hypoxic pO2 drives generation of a unique CD27++ B cell population, with enhanced antibody secreting cell differentiation capacity and Ig production upon restimulation (A) Quantification of percentage of CD27-CD38-, CD27+/-CD38-, CD27++CD38- and CD27++CD38++ cells on day 7 of culture (n = 5) (B) Representative biaxial flow cytometry plot of CD27 and CD38 expression, with heatmap depicting MFI expression of PAX5, BLIMP1 and XBP-1s on day 7. (C) gMFI of PAX5, BLIMP1 and XBP-1s in respective populations of CD27-CD38-, CD27+/-CD38-, CD27++CD38- and CD27++CD38++ cells on day 7 (n = 6) (D) Percentage of IgG+ B cells on day 7 of of culture at 1% pO2 within CD27++ CD38-, CD27+/- CD38- or CD27- CD38- populations. (n = 5) (E) Representative example of FACS sort gating strategy on day 7 to isolate CD27++ CD38-, CD27+/- CD38- or CD27- CD38- B cells with schematic experimental time line. (F) Quantification of %CD27+CD38+ cells by flow cytometry and IgG and IgM secretion by ELISA, 4 or 7 days after sort (day 11 or 14 of culture) (n = 5). (A-F) Bars represent means of biological replicates each composed of two technical replicates of (A, C, D) 2 or (F) 1 independent experiment (A) Differences in %gated cells were determined using mixed-effects analysis using Tukey’s test for multiple comparisons. (C, D, F) Differences in gMFI and % gated cells were determined using repeated measures one-way ANOVA using Tukey’s test for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 5
Figure 5
Time-dependent pO2 transitions alter naive B cell differentiation and IgG class switch recombination. (A) Representative biaxial CD27/CD38 FACS plots of 21, 3, 1% pO2 cultures and 1 – 3% pO2 transition cultures at day 3, 5 or 7 shown for day 7 and 11 of culture. (B) Quantification of CD27+CD38+ and CD27+CD38- B cells over time in culture (n = 11) (C) gMFI of BLIMP1 on day 7 (n = 3) (D) Frequency of IgM+ and IgG+ B cells on day 11 (n = 5). (E) CD138 expression within the CD27+CD38+ population (n = 5). (F) IgM and IgG levels were measured by ELISA in culture supernantant after 11 days (n = 11). Bars represent means of biological replicates each composed of two technical replicates of (B, F) 3, (D) 2 or (C, E) 1 independent experiment. (B) Statistical differences were determined using mixed-effects analysis using Tukey’s test for multiple comparisons (C-F) Differences in gMFI, % gated cells and Ig production were determined using repeated measures one-way ANOVA using Tukey’s test for multiple comparisons. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 6
Figure 6
pO2 as a critical driver of B cell differentiation in vitro. Schematic representation of the effect of differential pO2 on B cell differentiation and underlying signaling pathways.

References

    1. Elsner RA, Shlomchik MJ. Germinal center and extrafollicular b cell responses in vaccination, immunity and autoimmunity. Immunity (2020) 53(6):1136–50. : doi: 10.1016/j.immuni.2020.11.006 - DOI - PMC - PubMed
    1. Weisel FJ, Zuccarino-Catania GV, Chikina M, Shlomchik MJ. A temporal switch in the germinal center determines differential output of memory b and plasma cells. Immunity (2016) 44(1):116–30. doi: 10.1016/j.immuni.2015.12.004 - DOI - PMC - PubMed
    1. Laidlaw BJ, Cyster JG. Transcriptional regulation of memory b cell differentiation. Nat Rev Immunol (2021) 21(4):209–20. doi: 10.1038/s41577-020-00446-2 - DOI - PMC - PubMed
    1. Suan D, Kräutler NJ, Maag JLV, Butt D, Bourne K, Hermes JR, et al. . CCR6 defines memory b cell precursors in mouse and human germinal centers, revealing light-zone location and predominant low antigen affinity. Immunity (2017) 47(6):1142–1153.e4. doi: 10.1016/j.immuni.2017.11.022 - DOI - PubMed
    1. Cunningham AF, Gaspal F, Serre K, Mohr E, Henderson IR, Scott-Tucker A, et al. . Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J Immunol (2007) 178(10):6200–7. doi: 10.4049/jimmunol.178.10.6200 - DOI - PubMed

Publication types